Several of the drugs downregulating TRF1 expression interfere with common cancer signaling pathways including ERK and MEK, Aurora, CDK, PLK1, HSP90, mTOR, RTK, or chemotherapy drugs like gemcitabine and docetaxel. This evidence concerns the gene TERF1 and cancer.